Since 2025, U.S. measles outbreaks have triggered over 100 maternal measles infections during pregnancy, alongside cases of congenital measles in infants, and one likely case of pediatric meningoencephalitis, according to CDC analysis. Thirteen infants developed congenital measles between January 2025 and September 28, 2026. Sixty-six infants presented with symptoms including fever, rash, conjunctivitis, coryza, or cough.
Clinical Characteristics and Outcomes
One infant developed symptoms indicating meningoencephalitis. One hundred twelve confirmed cases of measles in pregnant women were reported across 16 U.S. jurisdictions. Ninety-eight percent of these women had not received measles, mumps, and rubella (MMR) vaccination before pregnancy, or had an unknown vaccination history. The two women who had received the MMR vaccine had single or two documented doses prior to pregnancy. Eleven of the women were hospitalized with measles complicated by pneumonia. Michael Osterholm stated that a large population of women of childbearing age were not vaccinated in the last 25 years, making them susceptible to measles. Measles in pregnancy is linked to serious outcomes for mothers and babies, including increased hospitalization rates, pneumonia, and neonatal intensive care unit admissions. Infants born to infected mothers were more likely to be preterm, have low birth weight, and develop conditions such as encephalitis, subacute sclerosing panencephalitis, and death. Postexposure prophylaxis, including intravenous immunoglobulin, is recommended for exposed women and infants. Twenty-three percent of the 112 pregnant women with measles infections were hospitalized for non-labor-related causes. Twenty-one pregnancies were reported with 14 days of the start of a maternal measles rash, resulting in 19 live births and two pregnancy losses. Eight of the 19 live births were preterm, and eight infants were admitted to a NICU. Most maternal measles cases (96%) were linked to outbreaks of at least 50 measles cases. MMR is not recommended during pregnancy due to its live-attenuated nature, emphasizing the importance of pre-pregnancy vaccination and community coverage.